Form 4 Tracker
Kura Oncology, Inc.
KURA

31 insider filings · Latest: Sep 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 28, 2026Sep 29 10:30 PMTeresa Brophy BairChief Legal Officer
Sale
8,442$10.50$88.6K187,002(D)

View →

Sep 29, 2026Sep 29 10:30 PMKathleen FordChief Operating Officer
Sale
3,668$10.75$39.4K142,986(D)

View →

Sep 28, 2026Sep 29 10:30 PMKathleen FordChief Operating Officer
Sale
6,906$10.50$72.5K146,654(D)

View →

Sep 29, 2026Sep 29 10:30 PMMollie LeoniChief Medical Officer
Sale
28,802$10.75$309.6K141,095(D)

View →

Sep 28, 2026Sep 29 10:30 PMMollie LeoniChief Medical Officer
Sale
12,448$10.50$130.7K169,897(D)

View →

Sep 28, 2026Sep 29 10:30 PMThomas James DoyleSVP, Finance & Accounting
Sale
4,607$10.50$48.4K142,428(D)

View →

Sep 29, 2026Sep 29 10:30 PMBrian T. PowlChief Commercial Officer
Sale
15,430$10.75$165.9K136,819(D)

View →

Sep 28, 2026Sep 29 10:30 PMBrian T. PowlChief Commercial Officer
Sale
17,020$10.53$179.2K152,249(D)

View →

Sep 29, 2026Sep 29 8:25 PMBRIAN POWL
Proposed Sale
15,430$10.61$163.7K—

View →

Sep 29, 2026Sep 29 8:25 PMMOLLIE LEONI
Proposed Sale
28,802$10.61$305.6K—

View →

Sep 29, 2026Sep 29 8:25 PMKATHLEEN FORD
Proposed Sale
3,668$10.61$38.9K—

View →

Sep 28, 2026Sep 29 1:00 AMPOWL BRIAN T
Proposed Sale
9,020$10.76$97.1K—

View →

Sep 28, 2026Sep 29 12:00 AMLEONI MOLLIE
Proposed Sale
12,448$10.76$133.9K—

View →

Sep 28, 2026Sep 29 12:00 AMFORD KATHLEEN
Proposed Sale
6,906$10.76$74.3K—

View →

Sep 28, 2026Sep 29 12:00 AMBAIR TERESA BROPHY
Proposed Sale
8,442$10.76$90.8K—

View →

Sep 28, 2026Sep 29 12:00 AMDOYLE THOMAS JAMES
Proposed Sale
4,607$10.76$49.6K—

View →

Sep 28, 2026Sep 28 8:20 PMBRIAN POWL
Proposed Sale
8,000$10.76$86.1K—

View →

Sep 24, 2026Sep 25 8:05 PMFrancis BurrowsChief Scientific Officer
Sale
20,726$10.83$224.5K42,327(D)

View →

Sep 24, 2026Sep 24 8:05 PMFRANCIS J BURROWS
Proposed Sale
20,726$10.83$224.5K—

View →

Aug 24, 2026Aug 24 9:30 PMTroy Edward WilsonDirector, President and CEO
Purchase
100,000$12.39$1.2M479,194(I)

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 24, 2026Sep 25 8:05 PMFrancis BurrowsChief Scientific Officer
Option Exercise
30,000$6.150(D)

View →

Sep 8, 2026Sep 10 8:30 PMJennifer FulkChief Financial Officer
Grant/Award
450,000$12.52450,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMDiane L. ParksDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMMichael VasconcellesDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMHasnain FaheemDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMHelen Louise CollinsDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMCarol SchaferDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMMary T SzelaDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 10:30 PMThomas MalleyDirector
Grant/Award
35,000$8.7735,000(D)

View →

Mar 23, 2026Mar 25 1:00 PMTroy Edward WilsonDirector, President and CEO
Option Exercise
6,103$6.150(D)

View →

Mar 18, 2026Mar 20 1:00 PMThomas MalleyDirector
Option Exercise
10,000$3.120(D)

View →